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Abstract
Background: Vitamin A and zinc are crucial for normal immune function, and may play a
synergistic role for reducing the risk of infection including malaria caused by Plasmodium falciparum.
Methods: A randomized, double-blind, placebo-controlled trial of a single dose of 200 000 IU of
vitamin A with daily zinc supplementation was done in children of Sourkoudougou village, Burkina
Faso. Children aged from 6 to 72 months were randomized to receive a single dose of 200 000 IU
of vitamin A plus 10 mg elemental zinc, six days a week (n = 74) or placebo (n = 74) for a period
of six months. Cross-sectional surveys were conducted at the beginning and the end of the study,
and children were evaluated daily for fever. Microscopic examination of blood smear was done in
the case of fever (temperature ≥37.5°C) for malaria parasite detection.
Results: At the end of the study we observed a significant decrease in the prevalence malaria in
the supplemented group (34%) compared to the placebo group (3.5%) (p < 0.001). Malaria episodes
were lower in the supplemented group (p = 0.029), with a 30.2% reduction of malaria cases (p =
0.025). Time to first malaria episode was longer in the supplemented group (p = 0.015). The
supplemented group also had 22% fewer fever episodes than the placebo group (p = 0.030).
Conclusion: These results suggest that combined vitamin A plus zinc supplementation reduces the
risk of fever and clinical malaria episodes among children, and thus may play a key role in malaria
control strategies for children in Africa.
Background
Malaria caused by Plasmodium falciparum remains a major
cause of morbidity and mortality among African children
[1]. Between 300 to 500 millions new cases of malaria,
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primarily due to P. falciparum, are annually observed in
the world, with 90% in sub-saharan Africa, and these
account for an estimated one million children deaths [2].
Furthermore, resistance to drugs and insecticides used to
fight this disease has hampered malaria control efforts [3].
Children and adults living in malaria-endemic areas often
have a high prevalence of malnutrition and deficiencies of
micronutrients such as vitamin A and zinc; this situation
creates a complexity of interactions with serious health
consequences [4,5].
Vitamin A is essential for normal immune function [6],
suggesting that it could play a role in protection against
malaria. Zinc is essential for many biological functions
such as protein synthesis, growth and immunity [7]. Vita-
min A metabolism requires normal zinc status, explaining
the frequent association of their deficiency [8]. Beneficial
protective effects of vitamin A or zinc on malaria-related
morbidity have been demonstrated in Papua New
Guinea, Peru and Zanzibari a [9-12]. Two randomized,
placebo-controlled trials conducted in Ghana (both
reported in a single publication) did not find an overall
significant effect of vitamin A on malaria parasitemia rates
or parasite densities although the studies showed a reduc-
tion of 23% and 32% of probable malaria illness in sup-
plemented children [13]. However, the number of
children with probable malaria was so small that this
study lacked adequate power to demonstrate an effect of
vitamin A on slide-confirmed malaria morbidity. In con-
trast to these studies that have suggested potential protec-
tive effects of vitamin A or zinc supplementation, a
randomized, placebo-controlled trial in Burkina Faso of
zinc supplementation failed to show a protective impact
on malaria episodes [13].
Given the evidence of a positive effect of these two micro-
nutrients when used individually on malaria [13,14], we
hypothesized that, due to the potentially synergistic effect
of vitamin A and zinc on immune function, dual supple-
mentation with these two micronutrients would decrease
morbidity due to P. falciparum malaria. We therefore per-
formed a randomized, double-blind, placebo-controlled
trial to assess the efficacy of combined of vitamin A and
zinc supplementation on morbidity due to P. falciparum
among young children in a malaria-endemic area of
Burkina Faso.
Methods
Study site
The study was done in Sourkoudougou village in Dandé
health district, which is located 25 km from Bobo Diou-
lasso city, Burkina Faso. Malaria is holoendemic, with
transmission peaking during the rainy season (May-Octo-
ber) and entomological inoculation rate of 697 infected
bites per person per year [15]. The village has a govern-
ment health centre where the children were examined.
Study design
Participants
Children aged from 6 to 72 months were recruited. Eligi-
bility criteria were: 1) age between 6 and 72 months; 2)
plan to reside in the village for at least the next 6 months;
3) middle upper arm circumference (MUAC) greater than
12.5 cm; 4) no ocular signs of vitamin A deficiency or his-
tory of night blindness; 5) no apparent chronic or debili-
tating condition; and 6) parental consent for the child's
participation. At enrolment each child underwent a med-
ical examination to detect malaria infection or other ill-
ness and all children received anti-malarial treatment with
sulfadoxine-pyrimethamine (SP) [16] in order to clear any
Plasmodium infection 7 days before the initiation of sup-
plementation. History of fever, cough, diarrhea, and
stomach ache, night blindness, and the use of mosquito
net on the previous night were recorded. Axillary temper-
ature, spleen size, MUAC, height (or length) and weight
were also recorded. Hemoglobin concentrations were
measured and thick and thin blood slides were prepared.
The study was reviewed and approved by the institutional
review board of Centre Muraz. An oral consent was
obtained from parents or guardian of children before
enrolment.
Randomization and micronutrients distribution and follow up
After enrolment, children were individually allocated vita-
min A plus zinc or placebo in two blocks by computer-
generated randomly permutated codes. The supplements
and placebos were packaged and provided by U-Pharma
of IRSS, Ouagadougou, in accordance with the random
numbers generated. All the capsules were indistinguisha-
ble in term of color odor or appearance. Capsules were
encoded for the two groups and these codes were kept off
site in a secure place that could not be accessed by the
study team, clinical staff, field workers, and parents. In the
supplemented group each child received a single capsule
of vitamin A contained 200 000 IU in 200 µl groundnut
oil and a capsule of zinc containing 10 mg of elemental
zinc, 6 days a week during a 6-month period. In the pla-
cebo group each child received a single capsule containing
groundnut oil alone (vitamin A placebo) and a daily pla-
cebo that consisted of a zinc-free capsule with maize pow-
der (zinc placebo), 6 days a week during 6 months.
Cross sectional survey and follow up
Two surveys were done – before and at the end of the
study. During these surveys the following data were col-
lected:
• Clinical & anthropometric data: history of fever, immu-
nization data, physical examination, height and weight
Nutrition Journal 2008, 7:7 http://www.nutritionj.com/content/7/1/7
Page 3 of 7
(page number not for citation purposes)
• Blood samples for hematology analysis and malaria par-
asite detection
During the follow up period, each child was visited daily
by a supplementation agent for zinc administration, and
for recording axillary temperature and any sign of illness.
Each child with fever (≥37.5°C) or history of fever had a
blood smear performed for malaria diagnosis and the par-
ents were invited to bring their child to the health centre
for clinical examination and treatment by the nurse. An
episode of P. falciparum malaria was defined as tempera-
ture ≥37.5° C, accompanied by the presence of asexual
forms of the parasite on blood smear and no other obvi-
ous cause for the illness. Malaria episodes were treated
with SP. Clinical examination, thick and thin blood
smears were repeated 3 and 7 days after the first positive
smear.
Laboratory procedures
Thick and thin Giemsa-stained blood films were reviewed
for the presence of Plasmodium species. The parasite count
per µl was done by counting 200 white blood cells and the
number expressed on the basis of 8000 WBC per µl [17].
Each film was examined by microscopy by a technician in
the field, and re-examined by two experienced laboratory
technicians and checked by a third investigator in cases of
1,5 discrepancy. Hemoglobin concentrations were deter-
mined by complete blood count with an automated coun-
ter (Coulter counter T540, Florida, USA).
Sample size
The primary outcome was the number of clinical episodes
of P. falciparum malaria. Assuming a prevalence rate of
50%[18] of malaria episodes in the placebo group with
80% power and α = 0.05, we hypothesized that combined
vitamin A and zinc supplementation would reduce the
prevalence rate by 50%. In this regard we calculated the
sample size (n = 75) for each group with a consideration
that 10% of participants would be lost to follow up. A
total of 150 children were randomly selected at the start of
the study.
Data processing and analysis
The number of P. falciparum malaria episodes was the pri-
mary outcome. Malaria was defined as axillary tempera-
ture ≥37.5°C with any level of parasitemia. Secondary
outcomes included the prevalence of other causes of mor-
bidity, and all cause mortality. The prevalence of diarrhea,
fever, and cough was calculated by the number of child
days of the respective disease divided by the total number
of days of observation. The geometric mean parasite den-
sity, hemoglobin concentration, and anthropometric
measurements were expressed as mean values.
The relative risk (RR) of P. falciparum malaria in children
supplemented with vitamin A and zinc was calculated as
the ratio of incidence densities between the supplemented
group and placebo group. To exclude recrudescent
malaria episodes, the individual observation time was
defined as the interval from the first to last day of obser-
vation minus 14 days for each defined episode. Student t
tests and chi square tests were used to compare continu-
ous and categorical variables, respectively. Wilcoxon test
was used for non-normal data. The Cox proportional haz-
ards analysis (Kaplan-Meier curve) was used to assess the
effect of combined vitamin A and zinc supplementation
on the time of appearance of first malaria episode. The
analyses were done with SPSS 11.0. Stata 8.0 was used for
the calculation of geometric mean parasite density. Epi
Info™, version 3.3.2, was used to analyze anthropometric
data. A p-value < 0.05 was considered as statistically sig-
nificant.
Results
One hundred fifty children were randomized (figure 1); 2
children were unavailable for analysis because they
migrated out of the study area (1 in each group). The base-
line characteristics of study children are given in Table 1.
The supplemented (n = 74) and placebo groups (n = 74)
were similar in terms of age, health centre attendance, bed
net use, and anthropometric indexes. The prevalence of P.
falciparum was higher in the vitamin A plus zinc group rel-
ative to the placebo group at baseline [76.0% vs. 61.0 %
(p = 0.05)]. There was no difference in mean parasite den-
sity, spleen enlargement, or mean hemoglobin concentra-
tions at baseline although the prevalence of severe anemia
was higher in the vitamin A and zinc supplemented
group.
Trial profileFigure 1
Trial profile.
150 Enrolled 
children
75 Randomly
assigned
75 Randomly 
assigned placebo
vitamin A + zinc
1 loss to
follow-up
1 loss to 
follow-up
74 In analysis, 74 In analysis, 
completed trial at 6 
months
completed trial at 6 
months
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At the end of the study, the prevalence of malaria was sig-
nificantly lower in the supplemented group (34% vs.
3.5%), respectively (p < 0.001). The mean parasite density
was higher in the placebo group compared to the supple-
mented group at the end of the study (p = 0.048). Consid-
ering the variation of the parasite density within each
group, we observed a significant decrease in the supple-
mented group from 1589 [1026–2459] to 1011 [647–
1579] (p < 0.001) and a significant increase in the placebo
group from 1444 [923–2259] to 1945 [1155–3275] (p =
0.023). At the end of the study, there was no difference in
the proportion of children with splenomegaly between
the two groups. Regarding nutritional parameters we
observed that wasting and stunting continued to be severe
in both groups (Table 1) and there was no change in the
supplemented or placebo groups, respectively, at the end
of the study. Mean hemoglobin rates were also similar in
the two groups, and did not change significantly after six
months. The proportion of children with anemia
decreased significantly in the supplemented group from
18.0% to 5.4% (p = 0.02) whereas there was no change in
the placebo group.
The weekly surveillance data showed that the mean
number of episodes of fever episodes per child was signif-
icantly higher in the placebo group (Table 2). Children in
the placebo group had a greater risk of having a fever epi-
sode than those in the supplemented group [RR = 1.28
(1.09–2.94), p = 0.030]. The mean number of malaria epi-
sodes per child was also significantly higher in the placebo
group. The RR of malaria episodes was 43% higher in the
placebo group [RR = 1.43 (1.10–2.40), p = 0.025].
Table 2: Supplementation impact on malaria and general morbidity
Placebo Supplemented RR (95% CI) p-value
Number of fever episodes (mean ± SD) 2.04 ± 1.2 1.63 ± 1.2 - 0.038
Number of malaria episodes (mean ± SD) 1.5 ± 1.005 1 ± 0.93 - 0.029
P*PFever episodes 153 119 1.28 (1.09–2.94) 0.030
P*PMalaria episodes 106 74 1.43 (1.10–2.40) 0.025
Free of pathologies 17% (9–25) 31% (16–46) - 0.05
Cough episodes 51,3 (40–62.6) 45,9% (34.6–57.2) - 0.510
Diarrhea episodes 52,7% (41.4–64) 28,3% (18.1–38.5) - 0.002
Geometric mean density P falciparum (asexual forms/µl) 10672 (7589–15007) 7704 (5409–10971) - 0.049
P*PNumber of episodes
Mean ± SD or % (CI 95%)
Child-years was 37 in each group
Table 1: Baseline and end of study characteristics of the study population
Baseline End of study
Placebo (n = 74) Supplemented (n = 74) p-value Placebo (n = 74) Supplemented (n = 74) p-value
Age (months) 35.2 ± 20 37.9 ± 20 0.72 - - -
Sex -
Female 45.9% 48.6% 0.74 - - -
Antecedent
Reported children with fever episode on the previous year‡ 78.30 (69–87.6) 89.20 (82.1–96.3) 0.041 - - -
Reported children with mosquito-net use on the previous 
night
52.7 (41.4–64.0) 56.7 (45.4–68.0) 0.62 - - -
Anthropometry
Weight-for-height Z- score <-2.0 -0.73 ± 2.8 -0.82 ± 1.4 0.58 -1.10 ± 2 -1.03 ± 1.3 0.80
Height-for-age Z- score <-2.0 -1.60 ± 2.3 -1.50 ± 2.0 0.77 -1.5 ± 2.4 -1.49 ± 1.7 0.97
Weight-for-height Z- score <-2.0 (%) 20.3 (11.2–29.4) 13.5 (5.7–21.3) 0.20 27.0 (17.0–37.0) 23.0 (13.5–32.5) 0.56
Height-for-age Z- score <-2.0 (%) 47.3 (36.0–58.6) 40.5 (29.3–51.7) 0.40 46.0 (34.7–57.3) 35.0 (24.2–45.8) 0.20
Hematology
Mean (SD) hemoglobin (g/dl) 9.4 ± 1.6 9.31 ± 2.3 0.75 10.21 ± 1.82 10.09 ± 1.97 0.70
Anemia ≤ 7.0 g/dl‡ (%) 5.4 (0.4–10.5) 18.0 (9.3–26.7) 0.020 5.4 (0.4–10.5) 5.4 (0.4–10.5) 0.71
Malariometric indices
Positive P. falciparum 61.0 (51–72) 76.0 (66.-85) 0.052 57.5% (46.2–68.8) 42.0% (32.8–55.2) 0.048
Geometric mean density P. falciparum positive asexual 
forms/µl 1444 (923–2259) 1589 (1026–2459) 0.38 1945 (1155–3275) 1011 (647–1579) 0.85
Enlarged spleen 61.0% (51–72) 58.0% (47–69) 0.73 57.0% (46–68) 53.0% (42–64) 0.62
Mean ± SD or % (CI 95%)
‡ p < 0.05
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The Cox proportional hazards analysis (Figure 2) showed
that the time to first episode of clinical malaria was signif-
icantly longer in the supplemented group than the pla-
cebo group (p = 0.016). Diarrhea episodes incidence were
significantly higher in placebo group (52.7 vs. 28.3 p =
0.002). But no significant differences were observed for
the incidence of cough between the two groups. Children
in the supplemented group were more likely to be free
from any episode of infection than those in placebo group
(p = 0.05) (Table 2).
Discussion
In this randomized trial we observed that combined sup-
plementation with vitamin A and zinc reduced the burden
of clinical attacks of malaria in young children by 30%.
These results suggest that vitamin A and zinc supplemen-
tation might play an important role in the prevention of
malaria. Vitamin A alone previously has been demon-
strated to lead to a reduction of malaria episodes by 30%
in Papua New Guinea [11]. Similarly, it was also observed
that zinc supplementation alone reduced P. falciparum-
attributable health attendance by 38% and by 69% for
malaria episodes with high parasite density ≥ 100 000/µl
[10]. When considering these previous studies [10,11],
our results are suggestive of a potential synergistic effect of
vitamin A and zinc on the reduction malaria episodes,
even with low levels of parasitemia. However, because
there were no groups of participants who received vitamin
A or zinc alone in the present study, the study design pre-
cludes determining whether the reduction in malaria epi-
sodes was additive or multiplicative (i.e., synergistic).
Mean parasite density observed during the follow up
period tended to occur at higher densities in the placebo
group. Prolongation of the time to first malaria episode
manifestation was observed in one zinc supplementation
study [10] but not in a vitamin A supplementation trial
[11], so this lends support to a zinc-specific effect. Zinc
appears to have an effect beyond an impact on malaria
alone as many studies have shown that zinc reduces mor-
bidity due to numerous infectious diseases [19-22]. Vita-
min A seems to have a positive impact in terms of the
number of malaria cases, independently from the P. falci-
parum parasitemia [9]. However, in previous studies in
Ghana and in Burkina Faso, no effect was found on the
number of falciparum malaria episodes or on mean para-
site density with the supplementation of zinc alone or
vitamin A alone [13,14].
One important limitation of our study was the imbalance
at randomization between the two study arms. For exam-
ple, the supplemented group had more children who were
parasitemic at baseline, more who had a history of fever,
and a greater proportion who were anemic. While the rad-
ical cure with SP should have resulted in the elimination
of these differences between the two groups, it is possible
that a greater intensity of past exposure to malaria in the
intervention group might have resulted in a greater degree
of acquired immunity which in turn could have led to a
slower rate of re-infection. However, another possibility is
that the study results are underestimating the true effect of
the combined vitamin A and zinc supplements because
the intervention group might have been subjected to a
greater intensity of malaria transmission.
We observed that the number of fever episodes was signif-
icantly lower in children who received the supplements.
In Papua New Guinea there was no effect of vitamin A
alone on the number of fever episodes [11]. This confirms
that the mechanism of action on malaria morbidity of
vitamin A or zinc remains complex. It has been demon-
strated that free retinol has a pharmacological effect
against malaria parasites [23], but the very low concentra-
tions of free retinol in the serum make its hypothetical
effect inconclusive [24] given the lack of association
between serum retinol concentration and malaria mor-
bidity found in Papua New Guinea [11]. In another zinc
supplementation study in Papua New Guinea [10], it was
observed that plasma zinc levels alone were not predictive
of susceptibility to malaria episodes, and despite the mod-
erate improvement of plasma zinc levels in the supple-
mented group, malaria-associated morbidity was strongly
reduced. These findings suggest that daily intake of zinc
could modify resistance to P. falciparum episodes though
pathways, perhaps at the cellular level, that are not fully
reflected in plasma zinc levels [10].
Kaplan-Meier survival analysis for the first clinical malaria epi-sode for supplemented and placebo groups of hildren (Log R nk; p = 0.016)Figure 2
Kaplan-Meier survival analysis for the first clinical malaria epi-
sode for supplemented and placebo groups of children (Log 
Rank; p = 0.016). The continuous and green line represents 
the group of children who's received the double supplemen-
tation with VA and zinc. The dashed purple line represents 
the placebo group of children.
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It is known that vitamin A has immunopotentiating activ-
ities [6]; zinc also is essential for normal immune function
[25]. Consequently, dual supplementation of these two
micronutrients may lead to enhanced acquisition of
immunity against falciparum malaria or to modified
resistance to malaria episodes through a pathway at the
cellular level [22]. These ideas are supported by the fact
that the mean number of fever and malaria episodes was
significantly lower in the supplemented group. Supple-
mentation with vitamin A as well as zinc, or a combina-
tion of the two, is recognised to have a positive impact on
anaemia [26-29], as observed in the current study.
Improvements in anaemia might have resulted in reduced
risk of fever and malaria rather than an immunododulat-
ing effect of the two micronutrients. Children in the sup-
plemented group were more likely to be free from any
pathological episode. Vitamin A supplementation pro-
vided simultaneously with expanded program on immu-
nization (EPI) campaigns adopted by most of African in
accordance with the recommendations of UNICEF repre-
sents a useful strategic approach to address the problem of
vitamin A deficiency. However current strategies have not
taken zinc supplementation into consideration with the
notable exception of diarrhoea treatment programs. Ours
findings suggest that dual supplementation with vitamin
A and zinc is effective against malaria, and that a longer
supplementation period might lead us to observe more
important beneficial effects. Ultimately, the more afford-
able and sustainable solution would be the incorporation
of vitamin A and zinc in food fortification for children.
Conclusion
This study disclosed the key role of micronutrients in the
reduction of children morbidity and mortality, liked to
infectious diseases and malaria in particular. Our results
suggest that combined supplementation with vitamin A
and zinc may effectively reduce malaria-associated mor-
bidity, and thus may play an important role in malaria
control strategies in African children.
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